Effects of rosiglitazone and metformin on pancreatic beta cell gene expression
Open accessAbstract
Aims/hypothesis Rosiglitazone and metformin are two oral antihyperglycaemic drugs used to treat type 2 diabetes. While both drugs have been shown to improve insulin-sensitive glucose uptake, the direct effects of these drugs on pancreatic beta cells is only now beginning to be clarified. The aim of the present study was to determine the direct effects of these agents on beta cell gene expression.Methods We used reporter gene analysis to examine the effects of rosiglitazone and metformin on the activity of the proinsulin and insulin promoter factor 1 (IPF1) gene promoters in the glucose-responsive mouse beta cell line Min6. Western blot and gel retardation analyses were used to examine the effects of both drugs on the regulation of IPF1 protein production, nuclear accumulation and DNA binding activity in both Min6 cells and isolated rat islets of Langerhans.Results Over 24 h, rosiglitazone promoted the nuclear accumulation of IPF1 and forkhead homeobox A2 (FOXA2), independently of glucose concentration, and stimulated a two-fold increase in the activity of the Ipf1 gene promoter (p<0.01). Stimulation of the Ipf1 promoter by rosiglitazone was unaffected by the presence of the peroxisome proliferator activated receptor gamma antagonist GW9662. No effect of either rosiglitazone or metformin was observed on proinsulin promoter activity. Metformin stimulated IPF1 nuclear accumulation and DNA binding activity in a time-dependent manner, with maximal effects observed after 2 h.Conclusions/interpretation Metformin and rosiglitazone have direct effects on beta cell gene expression, suggesting that these agents may play a previously unrecognised role in the direct regulation of pancreatic beta cell function.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metformin increases insulin gene expression, possibly by nuclear accumulation of pdx1 and improved DNA-binding activity.
“With respect to its effects on β-cell function, metformin was shown to increase insulin gene expression,346 possibly by nuclear accumulation of pdx1 and its subsequently improved DNA-binding activity.347”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [347]
Citation 346 is attached to the claim that metformin increases insulin gene expression; the proposed PDX1 mechanism has a separate citation. In the Results section, the cited paper instead reports no effect of metformin on proinsulin gene promoter activity in Min6 beta cells over 24 hours. The paper does report short-term IPF1 nuclear accumulation and increased DNA-binding activity, but that does not establish the expression claim attributed to citation 346 (page unavailable). (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Miyazaki, J., Araki, K., Yamato, E., Ikegami, H., Asano, T., Shibasaki, Y., Oka, Y., & Yamamura, K. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,267 · see citing works
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148 · see citing works
Fryer, L. G. D., Patel, A. P., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,030 · see citing works
Bailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593 · see citing works
Kaneto, H., Xu, G., FUJII, N. L., Kim, S., Bonner‐Weir, S., & Weir, G. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202066200 · Cited by 349 · see citing works
Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor
Waeber, G., Thompson, N. A., NICOD, P. H., & Bonny, C. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.11.8923459 · Cited by 348 · see citing works
Wu, K.-L., GANNON, M. A., Peshavaria, M., Offield, M. F., Henderson, E., Ray, M., Marks, A., Gamer, L. W., Wright, C. V. E., & Stein, R. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.6002 · Cited by 253 · see citing works
Macfarlane, W. M., McKinnon, C. M., Felton-Edkins, Z. A., Cragg, H., James, R. F. L., & Docherty, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.1011 · Cited by 219 · see citing works
Self-citationWolfrum, C., Besser, D., Luca, E., & Stoffel, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1931483100 · Cited by 209 · see citing works
German, M. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1781 · Cited by 208 · see citing works
The Islet β Cell-enriched MafA Activator Is a Key Regulator of Insulin Gene Transcription
Zhao, L., Guo, M. A., Matsuoka, T., Hagman, D. K., Parazzoli, S. D., Poitout, V., & Stein, R. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409475200 · Cited by 191 · see citing works
Macfarlane, W. M., Smith, S. B., James, R. F. L., Clifton, A. D., Doza, Y. N., Cohen, P., & Docherty, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20936 · Cited by 176 · see citing works
Self-citationLeclerc, I., Woltersdorf, W. W. W., Xavier, G. D. S., Rowe, R. L., Cross, S. E., Korbutt, G. S., Rajotte, R. V., Smith, R. M., & Rutter, G. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00532.2003 · Cited by 171 · see citing works
Patanè, G., Piro, S., Rabuazzo, A. M., Anello, M., Vigneri, R., & Purrello, F. (2000) · Diabetes · doi:10.2337/diabetes.49.5.735 · Cited by 169 · see citing works
Pancreatic β Cell-specific Transcription of thepdx-1 Gene
Gerrish, K., GANNON, M. A., Shih, D. Q., Henderson, E., Stoffel, M., Wright, C. V. E., & Stein, R. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3485 · Cited by 155 · see citing works
Lupi, R., Guerra, S. D., Marselli, L., Bugliani, M., Boggi, U., Mosca, F., Marchetti, P., & Prato, S. D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2002 · Cited by 151 · see citing works
Glucagon-Like Peptide-1 Regulates the Beta Cell Transcription Factor, PDX-1, in Insulinoma Cells
Wang, X., Cahill, C. M., Piñeyro, M. A., Zhou, J., Doyle, M. E., & Egan, J. M. (1999) · Endocrinology · doi:10.1210/endo.140.10.7158 · Cited by 139 · see citing works
Ishida, H., Takizawa, M., Ozawa, S., Nakamichi, Y., Yamaguchi, S., Katsuta, H., Tanaka, T., Maruyama, M., Katahira, H., Yoshimoto, K., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.021 · Cited by 138 · see citing works
Kefas, B. A., Cai, Y., Kerckhofs, K., Ling, Z., Martens, G. A., Heimberg, H., PIPELEERS, D. G., & de Casteele, M. V. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.003 · Cited by 135 · see citing works
Marshak, S., Benshushan, E., Shoshkes-Carmel, M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7583-7590.2000 · Cited by 118 · see citing works
Rafiq, I., Xavier, G. D. S., Hooper, S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15977 · Cited by 114 · see citing works
Iwata, M., Haruta, T., Usui, I., Takata, Y., Takano, A., Uno, T., Kawahara, J., Ueno, E., Sasaoka, T., Ishibashi, O., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1083 · Cited by 110 · see citing works
Effects of troglitazone and metformin on glucose and lipid metabolism
Lenhard, J. M., Kliewer, S. A., Paulik, M. A., Plunket, K. D., Lehmann, J. M., & Weiel, J. E. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00229-3 · Cited by 105 · see citing works
Ben-Shushan, E., Marshak, S., Shoshkes-Carmel, M., Cerasi, E., & Melloul, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009088200 · Cited by 104 · see citing works
Zeender, E., Maedler, K., Bosco, D., Berney, T., Donath, M. Y., & Halban, P. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0446 · Cited by 103 · see citing works
Brunmair, B., Gras, F., Neschen, S., Roden, M., Wagner, L., Waldhäusl, W. K., & Fürnsinn, C. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2309 · Cited by 102 · see citing works
Aramata, S., Han, S., Yasuda, K., & Kataoka, K. (2005) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2005.05.009 · Cited by 101 · see citing works
Jones, T., Sautter, M. C., Gaal, L. F. V., & Jones, N. P. (2003) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2003.00258.x · Cited by 100 · see citing works
Sumoylation of Pdx1 is associated with its nuclear localization and insulin gene activation
Kishi, A., Nakamura, T., Nishio, Y., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00390.2002 · Cited by 98 · see citing works
Thiazolidinediones: metabolic actions in vitro
Fürnsinn, C., & Waldhäusl, W. K. (2002) · Diabetologia · doi:10.1007/s00125-002-0899-1 · Cited by 93 · see citing works
Ovalle, F., & Bell, D. S. H. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2585 · Cited by 90 · see citing works
Walter, H., & bben, G. L. (2005) · Drugs · doi:10.2165/00003495-200565010-00001 · Cited by 74 · see citing works
Thiazolidinediones ? some recent developments
Stümvoll, M. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.7.1179 · Cited by 71 · see citing works
Macfarlane, W. M., Shepherd, R. M., Cosgrove, K. E., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.3.418 · Cited by 68 · see citing works
Self-citationβ-Cell rejuvenation with thiazolidinediones
Bell, D. S. H. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.010 · Cited by 63 · see citing works
Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes
Bailey, C. J., & Day, C. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00318.x · Cited by 51 · see citing works
Ligands of Peroxisome Proliferator-activated Receptor-γ Induce Apoptosis in AR42J Cells
Masamune, A., Satoh, K., Sakai, Y., et al. (2002) · Pancreas · doi:10.1097/00006676-200203000-00003 · Cited by 45 · see citing works
Blumentrath, J., Neye, H., & Verspohl, E. J. (2001) · Cell Biochemistry and Function · doi:10.1002/cbf.907 · Cited by 44 · see citing works
Regulation of the pdx1 gene promoter in pancreatic β-cells
Campbell, S. C., & Macfarlane, W. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02633-5 · Cited by 39 · see citing works
Self-citationGuillemain, G., Xavier, G. D. S., Rafiq, I., et al. (2004) · Biochemical Journal · doi:10.1042/bj20031549 · Cited by 25 · see citing works
Transcriptional regulation of the IAPP gene in pancreatic β-cells
Shepherd, L. M. A., Campbell, S. C., & Macfarlane, W. M. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2004.09.009 · Cited by 19 · see citing works
Self-citationRegulation of insulin gene expression by overlapping DNA-binding elements
Nishimura, W., Salameh, T. S., Kondo, T., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050970 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985 · see citing works
Kanda, Y., Shimoda, M., Hamamoto, S., Tawaramoto, K., Kawasaki, F., Hashiramoto, M., Nakashima, K., Matsuki, M., & Kaku, K. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00388.2009 · Cited by 63 · see citing works
Glucose plus metformin compared with glucose alone on β-cell function in mouse pancreatic islets
HASHEMITABAR, M., BAHRAMZADEH, S., SAREMY, S., & NEJADDEHBASHI, F. (2015) · Biomedical Reports · doi:10.3892/br.2015.476 · Cited by 21 · see citing works
- Authors
- Richardson, H., Campbell, S. C., Smith, S. A., & Macfarlane, W. M.
- Affiliations
- Newcastle University (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- Corresponding author
- Macfarlane, W. M.
- ORCID
- Macfarlane, W. M.
- Venue
- Diabetologia
- Published
- 2006-02-18
- Volume
- 49
- Issue
- 4
- Pages
- 685-696
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2020461632
- Cited by
- 34
- References
- 42
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2018: 1 · 2016: 3 · 2015: 1 · 2013: 3 · 2012: 1
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- University of Brighton Repository (University of Brighton) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- GlaxoSmithKline
- Diabetes UK
- Directorate for Biological Sciences
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- rosiglitazone, metformin, pancreatic beta cells, beta-cell gene expression, insulin promoter factor 1, FOXA2, type 2 diabetes, antidiabetic drugs, PPARγ, MIN6 cells, pancreatic islets, insulin secretion
- MeSH terms
- Rosiglitazone, Anilides, Animals, Cell Line, Cell Nucleus, DNA, Glucose, Metformin, Proinsulin, Promoter Regions, Genetic, Protein Binding, Time Factors, Trans-Activators, Gene Expression, Homeodomain Proteins, Active Transport, Cell Nucleus, Thiazolidinediones, Insulin-Secreting Cells, Mice, Rats, Hepatocyte Nuclear Factor 3-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review